刚刚!红杉中国约21亿抄底拜耳王牌抗生素

MedTrend医趋势
Oct 29, 2025

一免费参会,扫码报名一10月29日,据CareerIn投行PEVC报道,德国制药巨头拜耳集团(Bayer AG)已同意将其旗下抗生素药物Avelox(莫西沙星)相关业务及资产出售给红杉中国(HSG)。双方已签署股权购买协议(SPA),交易规模预计在1.6亿欧元(约合13.2亿人民币)至2.6亿欧元(约合21.5亿人民币)之间。据悉,此次交易涉及的核心资产包括Avelox的知识产权(IP)、品牌...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10